Serbia to Start Sale of Galenika Drugmaker in Early 2013

Serbia plans to start the sale of its drugmaker Galenika AD in early 2013, the government said in an e-mailed statement today.

The state may offer a stake in the Zemun, Serbia-based company to the European Bank for Reconstruction and Development, General Manager Zivomir Novakovic said on Oct. 30.

The company posted a loss of 122 million euros ($160 million) in 2011.

To contact the reporter on this story: Misha Savic in Belgrade at msavic2@bloomberg.net

To contact the editor responsible for this story: James M. Gomez at jagomez@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.